Breast Cancer and Chemo-amennorhea | Clinical Trial

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Sex eligibility

Female

Study type

Observational

Primary location

Clinique Saint Vincent, Rocourt, Liège, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

pre-menauposal breast cancer needed to be treat with chemotherapy -

Exclusion criteria

metastases menopausal

-

Treatment and study plan

Observational

Other

standard of care fore patients with non metastatic breast cancer

Primary outcomes

incidence and duration of the amenorrhea induced by chemotherapy

Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Other

Registry information

Official study title

Etude Prospective Multicentrique de l'aménorrhée Chimio-induite et de sa réversibilité Dans le Cancer du Sein Chez Des Patientes préménopausées Recevant Une chimiothérapie Adjuvante ou néoadjuvante. Etude Améno-Chimio.

Acronym: chemo-ameno

Important dates

Study start: 2011
Primary completion: 2013
Study completion: 2014
First posted: Jun 3, 2013
Registry last updated: Apr 10, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed